These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7729305)

  • 21. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
    Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF
    Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.
    Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein (a) is associated with basal insulin levels in patients with type 2 Diabetes Mellitus.
    Habib SS; Aslam M; Shah SF; Naveed AK
    Arq Bras Cardiol; 2009 Jul; 93(1):28-33. PubMed ID: 19838467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
    Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
    Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
    Alagözlü H; Gültekin F; Candan F
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
    Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
    Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors.
    Kirkman MS; Weinberger M; Landsman PB; Samsa GP; Shortliffe EA; Simel DL; Feussner JR
    Diabetes Care; 1994 Aug; 17(8):840-6. PubMed ID: 7956628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes.
    Kuusi T; Yki-Järvinen H; Kauppinen-Mäkelin R; Jauhiainen M; Ehnholm C; Kauppila M; Seppälä P; Viikari J; Kujansuu E; Rajala S
    Eur J Clin Invest; 1995 Mar; 25(3):194-200. PubMed ID: 7781667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
    Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
    Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?
    Laakso M; Rönnemaa T; Lehto S; Puukka P; Kallio V; Pyörälä K
    Diabetologia; 1995 Apr; 38(4):487-93. PubMed ID: 7796991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.
    Császár A; Dieplinger H; Sandholzer C; Karádi I; Juhász E; Drexel H; Halmos T; Romics L; Patsch JR; Utermann G
    Diabetologia; 1993 Jan; 36(1):47-51. PubMed ID: 8436252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.
    Wolffenbuttel BH; Leurs PB; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabet Med; 1993 Jun; 10(5):427-30. PubMed ID: 8334821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The atherogenic lipid profile is associated with type 2 diabetes and some of its treatment modalities.
    Lin M; Superko R; Williams P; Lim P; Pan J; Charles MA
    Diabetes Nutr Metab; 2003 Feb; 16(1):56-64. PubMed ID: 12848306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
    Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lp(a) concentrations in NIDDM.
    Haffner SM; Morales PA; Stern MP; Gruber MK
    Diabetes; 1992 Oct; 41(10):1267-72. PubMed ID: 1397699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoprotein Lp(a) in obesity.
    Donatelli M; Verga S; Vaccaro M; Russo V; Bucalo ML; Scarpinato A
    Diabetes Res; 1992; 20(4):127-31. PubMed ID: 1345006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albuminuria is an independent predictor of carotid intima-media thickness and atherosclerosis in NIDDM patients.
    Willey KA; Kidd JF; Harris JP; Xu ZR; Yue DK
    Diabetes Care; 1995 Nov; 18(11):1502-3. PubMed ID: 8722078
    [No Abstract]   [Full Text] [Related]  

  • 39. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
    Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease.
    Cheng SW; Ting AC; Wong J
    Eur J Vasc Endovasc Surg; 1997 Jul; 14(1):17-23. PubMed ID: 9290555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.